Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ai |
RCV002224334 | SCV002502572 | uncertain significance | not provided | 2021-10-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002487018 | SCV002787993 | uncertain significance | Hypertrophic cardiomyopathy 1; Dilated cardiomyopathy 1EE; Hypertrophic cardiomyopathy 14; Atrial septal defect 3; Sick sinus syndrome 3, susceptibility to | 2021-07-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004047208 | SCV003884501 | uncertain significance | Cardiovascular phenotype | 2023-01-18 | criteria provided, single submitter | clinical testing | The c.1961G>A (p.R654Q) alteration is located in exon 16 (coding exon 14) of the MYH6 gene. This alteration results from a G to A substitution at nucleotide position 1961, causing the arginine (R) at amino acid position 654 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |